Skip to Main Content

Author Details

Michael F Walsh
Memorial Sloan Kettering Cancer Center
2004
83
31
PMIDPaper TitleJournal TitlePublished Year
35944238Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and Opportunities.J Clin Oncol2023
37845474Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.Nat Med2023
37738546Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.JCO Precis Oncol2023
37262391Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome.JCO Precis Oncol2023
36744932Comprehensive analysis of germline drivers in endometrial cancer.J Natl Cancer Inst2023
36735656Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study.PLoS One2023
36593350Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations.NPJ Precis Oncol2023
36346689NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.Clin Cancer Res2023
36115772Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.Eur Urol2023
34810208Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations.Cancer Epidemiol Biomarkers Prev2022
35585047Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers.Nat Commun2022
35477182Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.Cancer Epidemiol Biomarkers Prev2022
35442743Toward more streamlined testing in pediatric oncology.Sci Adv2022
35675575Concurrent Germline <i>BRCA1</i>/<i>2</i> and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options.JCO Precis Oncol2022
35346574Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome.Genet Med2022
35833951Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.Clin Cancer Res2022
35971132Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.Genome Med2022
36041233Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.Cancer2022
35904492Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.Cancer Discov2022
36265117Germline <i>SMARCA4</i> Deletion as a Driver of Uterine Cancer: An Atypical Presentation.JCO Precis Oncol2022
35074424Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.Ann Oncol2022
34949653Cancer-Causative Mutations Occurring in Early Embryogenesis.Cancer Discov2022
34863587Inherited TP53 Variants and Risk of Prostate Cancer.Eur Urol2022
34675114Clinical and Functional Significance of TP53 Exon 4-Intron 4 Splice Junction Variants.Mol Cancer Res2022
33466343Molecular Changes in Retinoblastoma beyond <i>RB1</i>: Findings from Next-Generation Sequencing.Cancers (Basel)2021
36247821<i>RB1</i> Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma: Before and after Intra-arterial Chemotherapy.Ophthalmol Sci2021
33579957The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.Nat Commun2021
34654685Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.Eur Urol Oncol2021
34741162The context-specific role of germline pathogenicity in tumorigenesis.Nat Genet2021
34133209Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.J Clin Oncol2021
34250384Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient Population.JCO Precis Oncol2021
34240179Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome.J Natl Cancer Inst2021
34308366Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.Nat Cancer2021
31444830Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma.Hum Mutat2020
31922925Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.J Clin Oncol2020
31794323Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.J Clin Oncol2020
32676930Utilization of clinical genetic counseling among childhood and young adult cancer survivors in a registry trial.J Community Genet2020
32422154Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.Ophthalmology2020
32386119Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.Pediatr Blood Cancer2020
3232005011p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.Cancer2020
32532877Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.Cold Spring Harb Mol Case Stud2020
30376427Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.J Clin Oncol2019
31645348Histone H3K36I mutation in a metastatic histiocytic tumor of the skull and response to sarcoma chemotherapy.Cold Spring Harb Mol Case Stud2019
31768065Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.Nat Med2019
31648317ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.Blood Adv2019
32775946Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.JCO Precis Oncol2019
32923861Pathogenic Loss-of-Function Germline <i>TERT</i> Mutations in Patients With Solid Tumors.JCO Precis Oncol2019
30255452A synonymous germline variant PALB2 c.18G&gt;T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancers.Breast Cancer Res Treat2019
30894706Correction: Toward automation of germline variant curation in clinical cancer genetics.Genet Med2019
30787465Toward automation of germline variant curation in clinical cancer genetics.Genet Med2019
  • 1 - 50 of 83

Recommended Authors

Jung Kim
Clinical Genetics Branch, National Cancer Institute
Career Start Year 2017
Number of shared co-authors 5
Bailey Gallinger
University of Toronto
Career Start Year 2015
Number of shared co-authors 7
Ninad Oak
St. Jude Children's Research Hospital
Career Start Year 2014
Number of shared co-authors 16
Karen Ouyang
Invitae Corporation
Career Start Year 2013
Number of shared co-authors 2
Sarah M Nielsen
Invitae Corporation
Career Start Year 2011
Number of shared co-authors 13
Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 9
Natalie J??ger
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 23
Catherine E Cottrell
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 7
Jianling Ji
Children's Hospital Los Angeles
Career Start Year 2009
Number of shared co-authors 6
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Sigve Nakken
University of Oslo
Career Start Year 2007
Number of shared co-authors 1
Kilannin Krysiak
Washington University School of Medicine
Career Start Year 2007
Number of shared co-authors 18
Arezou A Ghazani
Brigham and Women's Hospital, USA Harvard Medical School
Career Start Year 2006
Number of shared co-authors 5
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 8
Matthew B Yurgelun
34Dana-Farber/Brigham and Women's Cancer Center.
Career Start Year 2005
Number of shared co-authors 7
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 4
David Jones
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 8
Rebecca Nagy
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 12
Douglas R Stewart
Clinical Genetics Branch, National Cancer Institute
Career Start Year 2003
Number of shared co-authors 10
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 26
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 9
Peter J Campbell
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 15
Jon Teague
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 10
Marilyn M Li
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 19
Louise Izatt
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 10
Edward D Esplin
Invitae Corporation
Career Start Year 1998
Number of shared co-authors 6
Adam Butler
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 10
Donald W Parsons
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 25
Clare Turnbull
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 10
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 25

Collaborators

Michael F Berger
Co-authored papers 28
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 23
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 19
Chaitanya Bandlamudi
Co-authored papers 12
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Co-authored papers 8
Kim E Nichols
St. Jude Children's Research Hospital
Co-authored papers 8
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 6
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 5
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Co-authored papers 5
Michael J Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Fergus J Couch
Mayo Clinic
Co-authored papers 4
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Chimene Kesserwan
National Institutes of Health
Co-authored papers 3
John Easton
St Jude Children's Research Hospital
Co-authored papers 3
Abraham Ari Hakimi
Co-authored papers 3
Michael N Edmonson
St. Jude Children's Research Hospital
Co-authored papers 3
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 3
Matthias A Karajannis
Co-authored papers 3
Franck Bourdeaut
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Co-authored papers 3
Christopher C Porter
Emory University School of Medicine
Co-authored papers 3
Jan J Molenaar
Co-authored papers 3
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 3
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Susan M Domchek
Co-authored papers 3
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Release 1.2